Genetic basis of attenuation of the Sabin oral poliovirus vaccines.
作者信息
Minor P D, Macadam A J, Stone D M, Almond J W
机构信息
National Institute for Biological Standards and Control, Division of Virology, Potters Bar, Herts, U.K.
出版信息
Biologicals. 1993 Dec;21(4):357-63. doi: 10.1006/biol.1993.1096.
PMID:8024751
Abstract
摘要
相似文献
1
Genetic basis of attenuation of the Sabin oral poliovirus vaccines.脊髓灰质炎减毒活疫苗（Sabin株）减毒的遗传基础。
Biologicals. 1993 Dec;21(4):357-63. doi: 10.1006/biol.1993.1096.
2
Attenuation and reversion of the Sabin vaccine strains of poliovirus.脊髓灰质炎病毒萨宾疫苗株的减毒与回复突变
Dev Biol Stand. 1993;78:17-26.
3
Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.脊髓灰质炎病毒萨宾2型毒株的突变与减毒表型的稳定性
Virology. 1999 May 25;258(1):152-60. doi: 10.1006/viro.1999.9718.
4
Significance of a newly identified attenuating mutation in Sabin 3 oral poliovirus vaccine.新发现的Sabin 3口服脊髓灰质炎疫苗减毒突变的意义
Dev Biol Stand. 1993;78:93-9; discussion 99-100.
5
Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates.脊髓灰质炎病毒2型Sabin疫苗株在灵长类动物中减毒的遗传基础。
Virology. 1993 Jan;192(1):18-26. doi: 10.1006/viro.1993.1003.
6
Poliovirus attenuation and pathogenesis in a transgenic mouse model for poliomyelitis.脊髓灰质炎转基因小鼠模型中脊髓灰质炎病毒的减毒与发病机制
Dev Biol Stand. 1993;78:109-16.
7
Development of candidates for new type 2 and type 3 oral poliovirus vaccines.新型2型和3型口服脊髓灰质炎疫苗候选产品的研发。
Dev Biol Stand. 1993;78:141-8.
8
9
Approaches to the construction of new candidate poliovirus type 3 vaccine strains.新型脊髓灰质炎病毒3型候选疫苗株的构建方法。
Dev Biol Stand. 1993;78:161-9; discussion 169-70.
10
Evolution and polymorphism of poliovirus genomes.脊髓灰质炎病毒基因组的进化与多态性
Biologicals. 1993 Dec;21(4):379-84. doi: 10.1006/biol.1993.1099.
引用本文的文献
1
Is it time to switch to a formulation other than the live attenuated poliovirus vaccine to prevent poliomyelitis?是否到了改用其他减毒活疫苗而非口服脊髓灰质炎减毒活疫苗来预防脊髓灰质炎的时候了？
Front Public Health. 2024 Jan 8;11:1284337. doi: 10.3389/fpubh.2023.1284337. eCollection 2023.
2
Polio endgame finish is in sight.
Nature. 2023 Jul;619(7968):36-38. doi: 10.1038/d41586-023-01773-9.
3
Enterovirus D68 Infection in Human Primary Airway and Brain Organoids: No Additional Role for Heparan Sulfate Binding for Neurotropism.肠道病毒 D68 感染人原代气道和脑类器官：硫酸乙酰肝素结合对嗜神经性无额外作用。
Microbiol Spectr. 2022 Oct 26;10(5):e0169422. doi: 10.1128/spectrum.01694-22. Epub 2022 Sep 26.
4
Vaccine-Derived Polioviruses, Central African Republic, 2019.疫苗衍生脊髓灰质炎病毒，中非共和国，2019 年。
Emerg Infect Dis. 2021 Feb;27(2):620-623. doi: 10.3201/eid2702.203173.
5
Enterovirus D68 molecular and cellular biology and pathogenesis.肠道病毒 D68 的分子、细胞生物学与发病机制。
J Biol Chem. 2021 Jan-Jun;296:100317. doi: 10.1016/j.jbc.2021.100317. Epub 2021 Jan 21.
6
Updated Characterization of Outbreak Response Strategies for 2019-2029: Impacts of Using a Novel Type 2 Oral Poliovirus Vaccine Strain.更新 2019-2029 年暴发应对策略的特征描述：使用新型 2 型口服脊髓灰质炎疫苗株的影响。
Risk Anal. 2021 Feb;41(2):329-348. doi: 10.1111/risa.13622. Epub 2020 Nov 10.
7
Rational design of a live-attenuated eastern equine encephalitis virus vaccine through informed mutation of virulence determinants.通过对毒力决定因素的有针对性突变，理性设计一种减毒活的东部马脑炎病毒疫苗。
PLoS Pathog. 2019 Feb 11;15(2):e1007584. doi: 10.1371/journal.ppat.1007584. eCollection 2019 Feb.
8
Exchanges of genomic domains between poliovirus and other cocirculating species C enteroviruses reveal a high degree of plasticity.基因组域在脊髓灰质炎病毒和其他共同循环的 C 肠道病毒之间的交换揭示了高度的可塑性。
Sci Rep. 2016 Dec 13;6:38831. doi: 10.1038/srep38831.
9
Vaccine-Derived Polioviruses and Children with Primary Immunodeficiency, Iran, 1995-2014.疫苗衍生脊髓灰质炎病毒与原发性免疫缺陷儿童，伊朗，1995 - 2014年
Emerg Infect Dis. 2016 Oct;22(10):1712-9. doi: 10.3201/eid2210.151071.
10
A Single Mutation in the VP1 of Enterovirus 71 Is Responsible for Increased Virulence and Neurotropism in Adult Interferon-Deficient Mice.肠道病毒71型VP1的单个突变导致成年干扰素缺陷小鼠的毒力增强和嗜神经性增加。
J Virol. 2016 Sep 12;90(19):8592-604. doi: 10.1128/JVI.01370-16. Print 2016 Oct 1.
Zotero 插件